Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prodromal bullous pemphigoid.

Philina M Lamb1, Edward Abell, Michael Tharp

  • 1Department of Dermatology, University of Pittsburgh School of Medicine, PA 15240, USA.

International Journal of Dermatology
|March 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study.

Journal of the American Academy of Dermatology·2024
Same author

A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab.

Clinical case reports·2020
Same author

Cholelithiasis and Biliary Cirrhosis in a 28-Year-Old Man.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2017
Same author

Multicenter photopheresis intervention trial in early-stage mycosis fungoides.

Clinical lymphoma, myeloma & leukemia·2011
Same author

Part III: phototherapy-induced purpura in the setting of transient porphyrinemia in a neonate.

Journal of drugs in dermatology : JDD·2011
Same author

Squamous cell carcinoma arising in discoid lupus erythematosus lesions of the ears infected with human papillomavirus.

Cutis·2010
Same journal

Updated Vitiligo Trends in the Burden of Psychiatric and Autoimmune Diseases.

International journal of dermatology·2026
Same journal

SENTINOLD and the Challenge of Meaningful Risk Prediction in Melanoma.

International journal of dermatology·2026
Same journal

The "Stamp-n-Tack" Technique: An Ink-Guided Precision Method for Anchoring Tissue After Releasing Facial Retaining Ligaments in Large Facial Flap Reconstruction.

International journal of dermatology·2026
Same journal

Counterfactual Dermatology With Generative Models.

International journal of dermatology·2026
Same journal

Correlation of Clinical and Histopathological Features With Anti-Desmoglein Antibody Profile in Pemphigus Patients.

International journal of dermatology·2026
Same journal

Paracetamol-Induced Generalized Bullous Fixed Drug Eruption With Positive Anti-BP230 Antibody and Confirmed With Oral Provocation Test in a Child: A Case Report From the Philippines.

International journal of dermatology·2026
See all related articles

Prodromal bullous pemphigoid (PBP) often presents with urticaria-like plaques in individuals around 70 years old. Early diagnosis and treatment with corticosteroids can improve outcomes for this autoimmune blistering disease.

Area of Science:

  • Dermatology
  • Autoimmune Blistering Diseases
  • Clinical Research

Background:

  • Prodromal bullous pemphigoid (PBP) poses diagnostic challenges.
  • Early identification of PBP is crucial to mitigate disease progression and reduce patient morbidity.
  • Understanding PBP's clinical features and treatment options is essential.

Purpose of the Study:

  • To describe the clinical presentations of PBP.
  • To outline current treatment modalities for PBP.
  • To analyze patient demographics and disease duration in PBP.

Main Methods:

  • Retrospective review of 53 patients diagnosed with PBP.
  • Analysis of patient demographics, clinical presentations, and treatment responses.

Related Experiment Videos

Main Results:

  • The average age of PBP presentation was 70.8 years.
  • The mean disease duration was 11.8 months.
  • Urticaria-like plaques were the most frequent presentation (67.9%), followed by eczema-like lesions (11.3%) and dermatitis herpetiformis-like lesions (9.4%).
  • Most patients responded favorably to low-dose systemic corticosteroids, tetracycline, and/or potent topical corticosteroids.

Conclusions:

  • PBP commonly affects individuals in their sixth to early seventh decades of life.
  • The average duration of PBP is approximately one year.
  • Urticaria-like plaques are the predominant clinical manifestation of PBP.